Pharmaceutical Investing La Jolla Pharmaceutical Company Gets European Commission Approval for GIAPREZA
Pharmaceutical Investing La Jolla Pharmaceutical Company Receives Orphan Designation from FDA for LJPC-0118
Pharmaceutical Investing La Jolla Pharmaceutical Company Announces U.S. FDA’s Grant of Breakthrough Therapy Designation for LJPC-0118
Pharmaceutical Investing La Jolla Pharmaceutical Company Announces European Medicines Agency Validation of Marketing Authorisation Application for GIAPREZA
Skyharbour's Partner North Shore Uranium Signs Exploration Agreement with English Rivers First Nation
NorthStar Gaming Launches Spring Tournament Series with Up To $100,000 Prize Pool on Slots, Parlay and Blackjack Tournaments
